Epsilon M&A Deal Report - Corvette Group Pharmaceutical Services

Transaction Multiples for the Valuation of Private Companies

Recipharm > Corvette Group Pharmaceutical Services

Announced Date : 19 August 2014

Type : Exit ,Acquisition of Majority Stake

Deal Value : Yes

Acquirer : Recipharm

Target: Corvette Group Pharmaceutical Services

Target Country: Italy

Sector of activity : Health, Pharmaceuticals & Biotechnology

Business Description :

> Corvette Pharmaceutical Services Group (consisting of Corvette Group SpA and L ...

No EMAT : 65701

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating ***

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Health, Pharmaceuticals & Biotechnology) = 1226

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
28/03/2014	Peters Surgical	Vitalitec International & Fimed	France	0
07/03/2011	Bridgepoint	Médipole Sud Santé	France	0

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database